Buccal Midazolam Versus Nasal or Oral Midazolam Sedation for Minor Invasive Procedures in Children
Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Currently Midazolam sedation is the standard of care for minor invasive procedures in
pediatric patients; its use is restricted to two routes of administration for this purpose
oral and intranasal.
A third route of administration (buccal) is tested and approved for seizure management. In
the investigators' study the researchers investigate the buccal route of administration
versus oral or intranasal administration for sedation. The investigators' hypothesis is that
buccal route of administration is more convenient than intranasal and better absorbed than
oral.